ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

116
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bullishCelltrion Inc
03 Apr 2020 13:52

More Celltrion Block Deals from Temasek Soon? It Seems So

Should we expect more block deals from Temasek? It seems that we should. It seems more evident now that Temasek isn't planning to stay at Celltrion...

Logo
366 Views
Share
bullishCelltrion Inc
01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
434 Views
Share
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
361 Views
Share
24 Mar 2020 17:51

Short Covering - The New Normal

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 20 March 2020, the...

Logo
338 Views
Share
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
309 Views
Share
x